Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. (LCTX) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 87 transactions totaling $11.3M, demonstrating a bullish sentiment with $5.9M in net insider flow. The most recent transaction on Dec 19, 2025 involved a transaction of 65 shares valued at $109.
LCTX Insider Activity Summary
Who Is Buying LCTX Stock?
No significant insider buying has been recorded for LCTX in the recent period.
Who Is Selling LCTX Stock?
No significant insider selling has been recorded for LCTX in the recent period.
Is Lineage Cell Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for LCTX is bullish with an Insider Alignment Score of 76/100 and a net flow of $5.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
LCTX Frequently Asked Questions
Understanding LCTX Insider Activity
Insider trading at Lineage Cell Therapeutics, Inc. (LCTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading LCTX stock, having executed 87 transactions in the past 90 days. The most active insider is Partners, L.p. Broadwood (Executive), who has made 2 transactions totaling $7.0M.
Related Tools
Track Lineage Cell Therapeutics, Inc. Insider Activity
Get notified when executives and directors at LCTX file new Form 4 transactions